0001140361-17-032398.txt : 20170816
0001140361-17-032398.hdr.sgml : 20170816
20170816121719
ACCESSION NUMBER: 0001140361-17-032398
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20170816
DATE AS OF CHANGE: 20170816
EFFECTIVENESS DATE: 20170816
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROTEON THERAPEUTICS INC
CENTRAL INDEX KEY: 0001359931
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-292913
FILM NUMBER: 171035751
BUSINESS ADDRESS:
STREET 1: 200 WEST STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-890-0102
MAIL ADDRESS:
STREET 1: 200 WEST STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
D
1
primary_doc.xml
X0708
D
LIVE
0001359931
PROTEON THERAPEUTICS INC
200 WEST STREET
WALTHAM
MA
MASSACHUSETTS
02451
781-890-0102
DELAWARE
None
None
Corporation
true
Timothy
P.
Noyes
c/o Proteon Therpeutics Inc.
200 West Street
Waltham
MA
MASSACHUSETTS
02451
Executive Officer
Director
Mr. Noyes is the President and Chief Executive Officer of the Issuer.
George
A.
Eldridge
c/o Proteon Therapeutics Inc.
200 West Street
Waltham
MA
MASSACHUSETTS
02451
Executive Officer
Mr. Eldridge is the Chief Financial Officer, Senior Vice President, Treasurer and Assistant Secretary of the Issuer.
Matthew
P.
Kowalsky
c/o Proteon Therapeutics Inc.
200 West Street
Waltham
MA
MASSACHUSETTS
02451
Executive Officer
Mr. Kowalsky is the Vice President of Legal and the Secretary of the Issuer.
Steven
K.
Burke, M.D.
c/o Proteon Therapeutics Inc.
200 West Street
Waltham
MA
MASSACHUSETTS
02451
Executive Officer
Dr. Burke is a Senior Vice President and the Chief Medical Officer of the Issuer.
Paul
J.
Hastings
c/o Proteon Therapeutics Inc.
200 West Street
Waltham
MA
MASSACHUSETTS
02451
Director
Hubert
Birner, Ph. D.
c/o Proteon Therapeutics Inc.
200 West Street
Waltham
MA
MASSACHUSETTS
02451
Director
Garen
Bohlin
c/o Proteon Therapeutics Inc.
200 West Street
Waltham
MA
MASSACHUSETTS
02451
Director
Scott
A.
Canute
c/o Proteon Therapeutics Inc.
200 West Street
Waltham
MA
MASSACHUSETTS
02451
Director
John
G.
Freund, M.D.
c/o Proteon Therapeutics Inc.
200 West Street
Waltham
MA
MASSACHUSETTS
02451
Director
Tim
Haines
c/o Proteon Therapeutics Inc.
200 West Street
Waltham
MA
MASSACHUSETTS
02451
Director
Tony
Kingsley
c/o Proteon Therapeutics Inc.
200 West Street
Waltham
MA
MASSACHUSETTS
02451
Director
Jonathan
Leff
c/o Proteon Therapeutics Inc.
200 West Street
Waltham
MA
MASSACHUSETTS
02451
Director
Daniel
P.
Gottlieb
c/o Proteon Therapeutics Inc.
200 West Street
Waltahm
MA
MASSACHUSETTS
02451
Executive Officer
Mr. Gottlieb is the Vice President of Corporate Development of the Issuer.
E.
Scott
Toner
c/o Proteon Therapeutics Inc.
200 West Street
Waltham
MA
MASSACHUSETTS
02451
Executive Officer
Mr. Toner is the Senior Vice President of Marketing of the Issuer.
Biotechnology
Decline to Disclose
- 06b
false
2017-08-02
false
true
true
true
true
Series A Convertible Preferred Stock which is convertible into Common Stock, $.001 par value.
false
0
22000000
22000000
0
false
11
0
0
0
false
PROTEON THERAPEUTICS INC
/s/ George A. Eldridge
George A. Eldridge
Sr. V.P. and Chief Financial Officer of the Issuer
2017-08-16